Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Prophylactic or therapeutic agent for cancer

A therapeutic agent and colorectal cancer technology, applied in the direction of medical preparations containing active ingredients, pharmaceutical formulas, antineoplastic drugs, etc., can solve the problems of unknown compound group cancer prevention or treatment effects, etc., to achieve inhibition of cancer cell proliferation, Improve the effect of reducing the survival rate and suppressing cancer metastasis

Pending Publication Date: 2021-10-29
TOHOKU UNIV +1
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, it has not been known so far that the compound group of the present application has a preventive or therapeutic effect on cancer.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Prophylactic or therapeutic agent for cancer
  • Prophylactic or therapeutic agent for cancer
  • Prophylactic or therapeutic agent for cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0117] 1. Materials and methods

[0118] [Compound group of the present application]

[0119] The specific two compounds included in the compound group of the present application (compound #1 of the present application and compound #2 of the present application) are respectively based on compound #5 (equivalent to Compound #1 of the present application) and compound #35 (equivalent to compound #2 of the present application) are synthesized by the synthetic method. In the cell migration test, Compound #1 of the present application and Compound #2 of the present application were dissolved in 100% DMSO and used.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention addresses the problem of providing a low molecule compound that has an effect of preventing or treating cancer. By administering a compound represented by formula (1), a compound represented by formula (2), etc. by, for example, oral administration, cancer such as bowel cancer can be prevented or treated.

Description

technical field [0001] The present invention relates to agents for preventing or treating cancer. Background technique [0002] In the age-adjusted death rate of Japanese people classified according to the main cause of death in the "Vital Statistics" of the Ministry of Health, Labor and Welfare of Japan, malignant tumor (cancer) has been ranked first since 1981, and the death rate caused by cancer has reached the highest level in recent years. It did not show a tendency to decrease, but showed a steady or slight increase. [0003] The most common feature of cancer cells is that they exhibit rapid and uncontrollable proliferation compared to normal cells. Taking advantage of this feature, cancer chemotherapy using a drug that is toxic to proliferative cells (ie, an anticancer drug) is performed. Nucleic acid synthesis inhibitors (for example, cyclophosphamide), antibiotics (for example, actinomycin D, bleomycin), metabolic antagonists (for example, 5-fluorouracil, methotre...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61P1/04A61P35/00A61P35/02A61P43/00A61K31/405
CPCA61P43/00A61K31/405A61P35/00A61P35/02A61P1/04A61K9/0053
Inventor 阿部高明大沼忍海野伦明林谦一郎
Owner TOHOKU UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products